Clinical Trial: Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
Study Status: Completed
Recruit Status: RECRUITING
Condition: Neurogenic Bladder
Study Type: INTERVENTIONAL
Official Title: Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
Brief Summary:
The purpose of this study is to evaluate and standardize the way providers perform OnabotulinumtoxinA (BTX-A) injections into the bladder for the diagnosis of neurogenic lower urinary tract dysfunction (NLUTD)/overactive bladder (OAB).NLUTD/OAB is a syndrome that affects many people, and includes urinary frequency, urinary urgency, urgency incontinence, and nocturia.This syndrome can be challenging to treat and often requires procedural management - including BTX-A injections into the bladder.
Read more